Loading organizations...
Emigrant Capital operates as the private investment division of Emigrant Bank, providing long-term equity and capital solutions. It focuses on established middle-market businesses across sectors like industrial technology, niche manufacturing, and value-added services. The firm employs a partnership approach, aiming to enhance portfolio companies' operational and growth objectives through strategic assistance.
Emigrant Capital was established in 1999, emerging as the private equity arm of Emigrant Bank. Its formation leveraged the bank's deep roots and extensive history as a trusted New York City institution, founded in 1850. The initiative allowed Emigrant Bank to extend its financial expertise into direct investments, aiming to support promising businesses beyond traditional lending.
The firm partners with middle-market businesses seeking growth capital and strategic guidance to scale their operations. Emigrant Capital’s overarching vision is to act as a supportive equity partner, utilizing its parent bank's legacy and resources to help companies achieve sustained development and market leadership. It aims to build value by fostering long-term relationships and contributing operational insights.
Emigrant Capital has 2 tracked investments across 1 company. The latest tracked deal is $42.0M Series B in Frequency Therapeutics in January 2019.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jan 1, 2019 | Frequency Therapeutics | $42.0M Series B | Axil Capital | Joel Marcus, Marc Cohen, DF Investments, Korea Investment Partners, Polaris Founders Capital, Daguan Wang |
| Apr 11, 2017 | Frequency Therapeutics | $32.0M Series A | Marc Cohen | Alexandria Venture Investments, Korea Investment Partners, Morningside Ventures |